Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease

Background: Spironolactone, a non-selective mineralocorticoid receptor antagonist, can protect against cardiac fibrosis and left ventricular dysfunction, and improve endothelial dysfunction and proteinuria. However, the safety and effects of spironolactone on patient-centered cardiovascular and rena...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chen-Ta, Kor, Chew-Teng, Hsieh, Yao-Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262621/
https://www.ncbi.nlm.nih.gov/pubmed/30469400
http://dx.doi.org/10.3390/jcm7110459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262621/
https://www.ncbi.nlm.nih.gov/pubmed/30469400
http://dx.doi.org/10.3390/jcm7110459

Ejemplares similares